Keyphrases
Active Surveillance
30%
Alpha Wave
37%
Antibodies Neutralizing
30%
Antibody Persistence
30%
Budget Impact Assessment
30%
Capture-recapture
30%
Case Coverage
30%
Case Detection Rate
30%
Case Notification
30%
Catalonia
30%
Childhood Vaccination
30%
Clinical Trials
30%
Cognitive Behavioral Intervention
30%
Community Intervention
30%
Community Surveillance
30%
Confidence Interval
25%
Cost-effectiveness Analysis
30%
COVID-19
60%
COVID-19 Outbreak
30%
COVID-19 Vaccination
58%
COVID-19 Vaccination Coverage
60%
D-Wave
37%
Design Considerations
30%
Disease Severity
33%
Duration of Positivity
30%
East London
30%
Egypt
30%
Electronic Health Records
30%
Engagement Tools
30%
Ethnic Minorities
30%
Female Sex Workers
30%
GBMSM
30%
GitHub Repositories
30%
Guatemala
30%
High Risk
31%
High-risk Heterosexuals
26%
Hospitalization
33%
Hospitalization Risk
24%
Household Contacts
30%
Household Study
30%
Human Behavior
30%
Infected Individual
39%
Infection Rate
39%
Infection Risk
35%
Influenza
30%
Latent Tuberculosis Infection
30%
Low Back Pain
30%
Low-resource Countries
30%
Measles
30%
Migrants
60%
Mpox
30%
National Investigation
30%
Neutralizing Activity
30%
Non-EU Migrants
60%
Nursery
30%
O157
30%
Omicron Wave
37%
One Dose
30%
Pandemic H1N1 Influenza
30%
Patient Engagement
30%
Pilot Randomized Controlled Trial
30%
Poliovirus
30%
Politicians
24%
Population-based Cohort Study
30%
Pre-exposure Prophylaxis (PrEP)
30%
Pregnant Women
30%
Primary Care
53%
Primary School Students
60%
Rapid Spread
30%
Recapture Study
30%
Receptor-binding Domain
30%
Refugees
60%
Risk Factors
47%
SARS-CoV-2 Infection
100%
SARS-CoV-2 Variants
60%
School Staff
60%
School Year
30%
Second Dose
24%
Secondary School Students
30%
Sectional Approach
30%
Serogroup
30%
Sexually Transmitted Infection Clinic
30%
Sexually Transmitted Infections
30%
Shiga Toxin-producing Escherichia Coli
30%
Skills Training
30%
Smallpox Vaccine
30%
Third Dose
24%
Tuberculosis
90%
Tuberculosis Incidence
36%
Two-wave
30%
Underserved
30%
United Kingdom
60%
Vaccination
66%
Vaccination Coverage
28%
Vaccination Status
26%
Vaccine Impact
30%
Vaccine Uptake
33%
Vaccinium
30%
Validated Approach
30%
Virological Response
30%
Medicine and Dentistry
Case Management
7%
Chlamydia Infection
6%
Clinician
9%
Cohort Analysis
30%
Community-Based Intervention
30%
Comorbidity
9%
COVID-19
30%
COVID-19 Vaccination
60%
Cross Sectional Study
5%
Digital Health
5%
Diseases
39%
Electronic Health Record
30%
Electronic Prescribing
9%
Enterovirus
5%
Exanthem
7%
Gene Linkage
30%
General Practitioner
9%
Gonorrhea
6%
Hazard Ratio
7%
Health Service
9%
Human Immunodeficiency Virus
30%
Infection
18%
Infection Prevention
9%
Influenza Vaccination
20%
Intention-to-Treat Analysis
9%
Interferon Gamma Release Assay
30%
Latent Tuberculosis
30%
Measles
39%
Men Who Have Sex with Men
10%
Monkeypox
7%
Mumps
9%
Observational Study
30%
Poliomyelitis Virus
30%
Population Size
7%
Prevalence
30%
Primary Health Care
16%
Public Health
14%
Randomized Controlled Trial
30%
Rubella
12%
Serotype
30%
Sex Worker
27%
Shiga Toxin Producing Escherichia Coli
30%
Single Drug Dose
7%
Smallpox Vaccine
30%
Sputum Smear
20%
Subacute Sclerosing Panencephalitis
5%
Surveillance System
25%
Syphilis
15%
Trichomoniasis
6%
Tuberculosis Diagnosis
7%
Underserved Population
9%
Vaccination Coverage
42%
Vaccinia
30%